N K Webber, C M Elston, E A O'Toole. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acitretin/administration & dosageAdultArthritis, Psoriatic/complicationsArthritis, Psoriatic/drug therapyCryptogenic Organizing Pneumonia/complicationsCryptogenic Organizing Pneumonia/diagnosisCryptogenic Organizing Pneumonia/drug therapyCyclosporine/adverse effectsDermatologic Agents/adverse effectsEtanerceptFatal OutcomeFemaleHumansImmunoglobulin G/administration & dosageImmunoglobulin G/adverse effectsProtein C Inhibitor/administration & dosagePsoriasis/complicationsPsoriasis/drug therapyReceptors, Tumor Necrosis Factor/administration & dosage
Substances： See more » Dermatologic AgentsImmunoglobulin GProtein C InhibitorReceptors, Tumor Necrosis FactorCyclosporineAcitretinEtanercept
Year: 2008 PMID： 18241268 DOI： 10.1111/j.1365-2133.2007.08421.x
Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302